Search Results for keywords:"National Institutes of Health"

The National Institute of Diabetes and Digestive and Kidney Diseases is holding a closed meeting on April 29, 2025. The meeting will be virtual and run from 2:00 p.m. to 5:00 p.m. The purpose of the meeting is to review and evaluate cooperative agreement applications related to diabetic nephropathy in type 1 diabetes. Access to the meeting is restricted to protect personal privacy and confidential information.

The National Institute on Aging has announced a closed virtual meeting scheduled for April 18, 2025. This meeting will be conducted from 12:00 p.m. to 3:30 p.m. to review and evaluate grant applications. The meeting is closed to the public to protect confidential information and personal privacy. Ivan Tadeu Rebustini, Ph.D., is the contact person for this meeting.

The Center for Scientific Review, part of the National Institutes of Health (NIH), announced upcoming closed meetings to review grant applications. These meetings, scheduled for April 2025, are not open to the public because they will discuss confidential information such as trade secrets and personal details. Meetings will cover topics like addiction risks, neurobehavioral studies, and epidemiology. They will be held virtually, and interested parties can contact the designated Scientific Review Officers for further information.

The National Institute on Minority Health and Health Disparities has announced several upcoming closed meetings as part of reviewing grants and proposals aimed at addressing health disparities. These virtual meetings, scheduled between April 15 and April 30, 2025, will feature the evaluation of various health initiatives focusing on minority groups and underserved communities. The meetings are closed to the public due to the sensitive nature of the discussions, which may involve confidential information such as trade secrets and personal data. Each committee has a designated contact person for more information.

The National Institute on Aging will hold a closed meeting on February 26, 2021, to review and evaluate grant applications. This meeting, which will take place via video conference, involves sensitive discussions about confidential trade secrets and personal information, necessitating confidentiality under federal law. The meeting is organized by Dr. Dario Dieguez, Jr., who is the contact person for further details. The closed nature of the meeting aims to protect privacy and commercial interests.

The National Advisory Dental and Craniofacial Research Council is having a meeting on April 18, 2025. The meeting will be closed to the public to protect confidential information, including trade secrets and personal details about individuals involved with grant applications. The agenda includes reviewing a report to the council and evaluating grant applications. The meeting will be held virtually, and further details and an agenda will be available on the National Institute of Dental & Craniofacial Research's website.

The National Cancer Institute (NCI), which is part of the National Institutes of Health (NIH), is considering giving Ziopharm Oncology, Inc. an exclusive patent license to develop and market certain cancer therapies. These therapies involve using a patient's own T cells that are engineered to target specific mutations in the P53 gene, which is commonly mutated in many cancers. The license will cover treatments made through a method known as transposon-mediated gene transfer but will not include those made using CRISPR technology. Interested parties have until February 9, 2021, to submit comments or license applications.

The National Institutes of Health (NIH) has announced two upcoming closed meetings of the National Institute on Drug Abuse Special Emphasis Panel. These meetings will take place on April 11 and April 30, 2025, and will focus on reviewing grant applications related to device-based treatments for substance use disorders and the relationship between stimulants and HIV. Due to confidential information being discussed, such as personal data and potential trade secrets, these meetings will not be open to the public. Both meetings will be held virtually.

The National Institute of Arthritis and Musculoskeletal and Skin Diseases, part of the Health and Human Services Department, announced a closed meeting to review grant applications on March 24, 2021. The meeting will be conducted virtually and is closed to the public to protect confidential information, including trade secrets and personal data. Dr. Nakia C. Brown will oversee the review as the Scientific Review Officer.

The National Institutes of Health (NIH) will hold several closed meetings to review and evaluate grant applications. These meetings, organized by the Center for Scientific Review, are scheduled to take place from February 24 to March 2, 2021, and will be conducted as virtual meetings. The meetings cover a wide range of scientific topics, including biobehavioral processes, brain disorders, genetic research, cancer studies, healthcare methodologies, and drug discovery. The sessions are closed to ensure the confidentiality of trade secrets or personal information.